Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from QuantumPharm, Inc. ( (HK:2228) ).
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., has announced a new share placement under a general mandate. The company plans to issue up to 342,288,000 new shares at a price of HK$6.10 each, representing approximately 9.31% of its current issued share capital. The placement price is set at a discount compared to recent closing prices, with the transaction expected to raise gross proceeds of around HK$2,088 million. The net proceeds are estimated at HK$2,080 million, and the shares will be issued without requiring additional shareholder approval. The placement’s completion is contingent on specific conditions, and the company advises shareholders and potential investors to exercise caution.
More about QuantumPharm, Inc.
YTD Price Performance: 14.55%
Average Trading Volume: 121,947,169
Technical Sentiment Consensus Rating: Strong Sell
For detailed information about 2228 stock, go to TipRanks’ Stock Analysis page.